A critical advance in cancer investigation is occurring with the use of mini-antibodies to reactivate damaged p53. This essential tumor inhibitor protein is frequently lost in several types of cancer, leading https://bookmarkstime.com/story22680564/vhh-fragments-revive-the-p53-protein-the-new-pathway-for-tumor-treatment